Plasma lipid profiling in a large population-based cohort

Journal of Lipid Research

Volumn 54, Issue 10, 2013, Pages 2898-2908

  Weir, Jacquelyn M ^a   Wong, Gerard ^a   Barlow, Christopher K ^a   Greeve, Melissa A ^a   Kowalczyk, Adam ^b   Almasy, Laura ^c   Comuzzie, Anthony G ^c   Mahaney, Michael C ^c   Jowett, Jeremy B M ^a   Shaw, Jonathan ^a   Curran, Joanne E ^c   Blangero, John ^c   Meikle, Peter J ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Cardiovascular disease; Disease risk; Lipidomics; Mass spectrometry; Obesity

Indexed keywords

CERAMIDE; CHOLESTEROL ESTER; GLYCEROLIPID; LIPID; LYSOPHOSPHOLIPID; PHOSPHOLIPID; SPHINGOLIPID; SPHINGOMYELIN; TRIACYLGLYCEROL;

ADULT; AGE; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; COHORT ANALYSIS; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; LIFESTYLE; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIQUID CHROMATOGRAPHY; MALE; OBESITY; PRIORITY JOURNAL; SEX; SMOKING; TANDEM MASS SPECTROMETRY;

CARDIOVASCULAR DISEASE; DISEASE RISK; LIPIDOMICS; MASS SPECTROMETRY; OBESITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD CHEMICAL ANALYSIS; COHORT STUDIES; FEMALE; HUMANS; LIPIDS; MALE; MEXICAN AMERICANS; MIDDLE AGED; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84884141131     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P035808     Document Type: Article

References (49)

1. Quehenberger, O., and E. A. Dennis. 2011. The human plasma lipidome. N. Engl. J. Med. 365: 1812-1823.
2. Quehenberger, O., A. M. Armando, A. H. Brown, S. B. Milne, D. S. Myers, A. H. Merrill, S. Bandyopadhyay, K. N. Jones, S. Kelly, R. L. Shaner, et al. 2010. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 51: 3299-3305.
3. Pietiläinen, K. H., M. Sysi-Aho, A. Rissanen, T. Seppänen-Laakso, H. Yki-Järvinen, J. Kaprio, and M. Oresic. 2007. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects-a monozygotic twin study. PLoS ONE. 2: e218.
4. Graessler, J., D. Schwudke, P. E. Schwarz, R. Herzog, A. Shevchenko, and S. R. Bornstein. 2009. Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS ONE. 4: e6261.
5. Wang-Sattler, R., Y. Yu, K. Mittelstrass, E. Lattka, E. Altmaier, C. Gieger, K. H. Ladwig, N. Dahmen, K. M. Weinberger, P. Hao, et al. 2008. Metabolic profiling reveals distinct variations linked to nicotine consumption in humans-first results from the KORA study. PLoS ONE. 3: e3863.
6. Ollero, M., G. Astarita, I. C. Guerrera, I. Sermet-Gaudelus, S. Trudel, D. Piomelli, and A. Edelman. 2011. Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients. J. Lipid Res. 52: 1011-1022.
7. Schwab, U., T. Seppänen-Laakso, L. Yetukuri, J. Agren, M. Kolehmainen, D. E. Laaksonen, A-L. Ruskeepää, H. Gylling, M. Uusitupa, M. Oresic; GENOBIN Study Group. 2008. Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism-the GENOBIN study. PLoS ONE. 3: e2630.
8. Rhee, E. P., S. Cheng, M. G. Larson, G. A. Walford, G. D. Lewis, E. McCabe, E. Yang, L. Farrell, C. S. Fox, C. J. O'Donnell, et al. 2011. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J. Clin. Invest. 121: 1402-1411.
9. Han, X., K. Yang, and R. W. Gross. 2012. Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass Spectrom. Rev. 31: 134-178.
10. Mitchell, B. D., C. M. Kammerer, J. Blangero, M. C. Mahaney, D. L. Rainwater, B. Dyke, J. E. Hixson, R. D. Henkel, R. M. Sharp, A. G. Comuzzie, et al. 1996. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation. 94: 2159-2170.
11. Arar, N. H., V. S. Voruganti, S. D. Nath, F. Thameem, R. Bauer, S. A. Cole, J. Blangero, J. W. MacCluer, A. G. Comuzzie, and H. E. Abboud. 2008. A genome-wide search for linkage to chronic kidney disease in a community-based sample: the SAFHS. Nephrol. Dial. Transplant. 23: 3184-3191.
12. Hixson, J. E., and J. Blangero. 2000. Genomic searches for genes that influence atherosclerosis and its risk factors. Ann. N. Y. Acad. Sci. 902: 1-7.
13. Burke, J. P., R. Duggirala, D. E. Hale, J. Blangero, and M. P. Stern. 2000. Genetic basis of acanthosis nigricans in Mexican Americans and its association with phenotypes related to type 2 diabetes. Hum. Genet. 106: 467-472.
14. Atwood, L. D., P. B. Samollow, J. E. Hixson, M. P. Stern, and J. W. MacCluer. 2001. Genome-wide linkage analysis of pulse pressure in Mexican Americans. Hypertension. 37: 425-428.
15. Cai, G., S. A. Cole, J. H. Freeland-Graves, J. W. MacCluer, J. Blangero, and A. G. Comuzzie. 2004. Genome-wide scans reveal quantitative trait Loci on 8p and 13q related to insulin action and glucose metabolism: the San Antonio Family Heart Study. Diabetes. 53: 1369-1374.
16. Meikle, P. J., G. Wong, D. Tsorotes, C. K. Barlow, J. M. Weir, M. J. Christopher, G. L. MacIntosh, B. Goudey, L. Stern, A. Kowalczyk, et al. 2011. Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 31: 2723-2732.
17. Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B. 57: 289-300.
18. Henstridge, D. C., C. R. Bruce, C. P. Pang, G. I. Lancaster, T. L. Allen, E. Estevez, T. Gardner, J. M. Weir, P. J. Meikle, K. S. Lam, et al. 2012. Skeletal muscle-specific overproduction of constitutively activated c-Jun N-terminal kinase (JNK) induces insulin resistance in mice. Diabetologia. 55: 2769-2778.
19. Lam, Y. Y., G. Hatzinikolas, J. M. Weir, A. Janovska, A. J. McAinch, P. Game, P. J. Meikle, and G. A. Wittert. 2011. Insulin-stimulated glucose uptake and pathways regulating energy metabolism in skeletal muscle cells: the effects of subcutaneous and visceral fat, and long-chain saturated, n-3 and n-6 polyunsaturated fatty acids. Biochim. Biophys. Acta. 1811: 468-475.
20. Kamili, A., E. Wat, R. W. Chung, S. Tandy, J. M. Weir, P. J. Meikle, and J. S. Cohn. 2010. Hepatic accumulation of intestinal cholesterol is decreased and fecal cholesterol excretion is increased in mice fed a high-fat diet supplemented with milk phospholipids. Nutr. Metab. (Lond). 7: 90.
21. Smyth, I., D. F. Hacking, A. A. Hilton, N. Mukhamedova, P. J. Meikle, S. Ellis, K. Satterley, J. E. Collinge, C. A. de Graaf, M. Bahlo, et al. 2008. A mouse model of harlequin ichthyosis delineates a key role for Abca12 in lipid homeostasis. PLoS Genet. 4: e1000192.
22. Sozo, F., M. Vela, V. Stokes, K. Kenna, P. J. Meikle, R. De Matteo, D. Walker, J. Brien, A. Bocking, and R. Harding. 2011. Effects of prenatal ethanol exposure on the lungs of postnatal lambs. Am. J. Physiol. Lung Cell. Mol. Physiol. 300: L139 - L147.
23. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497-509.
24. Jung, H. R., T. Sylvanne, K. M. Koistinen, K. Tarasov, D. Kauhanen, and K. Ekroos. 2011. High throughput quantitative molecular lipidomics. Biochim. Biophys. Acta. 1811: 925-934.
25. Löfgren, L., M. Ståhlman, G. B. Forsberg, S. Saarinen, R. Nilsson, and G. I. Hansson. 2012. The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma. J. Lipid Res. 53: 1690-1700.
26. Hu, C., R. van der Heijden, M. Wang, J. van der Greef, T. Hankemeier, and G. Xu. 2009. Analytical strategies in lipidomics and applications in disease biomarker discovery. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 2836-2846.
27. Sommer, U., H. Herscovitz, F. K. Welty, and C. E. Costello. 2006. LC-MS-based method for the qualitative and quantitative analysis of complex lipid mixtures. J. Lipid Res. 47: 804-814.
28. Mitchell, T. W., H. Pham, M. C. Thomas, and S. J. Blanksby. 2009. Identification of double bond position in lipids: from GC to OzID. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 2722-2735.
29. Han, X., and R. W. Gross. 1994. Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. Proc. Natl. Acad. Sci. USA. 91: 10635-10639.
30. Han, X., K. Yang, J. Yang, K. N. Fikes, H. Cheng, and R. W. Gross. 2006. Factors influencing the electrospray intrasource separation and selective ionization of glycerophospholipids. J. Am. Soc. Mass Spectrom. 17: 264-274.
31. Hutchins, P. M., R. M. Barkley, and R. C. Murphy. 2008. Separation of cellular nonpolar neutral lipids by normal-phase chromatography and analysis by electrospray ionization mass spectrometry. J. Lipid Res. 49: 804-813.
32. Shaner, R. L., J. C. Allegood, H. Park, E. Wang, S. Kelly, C. A. Haynes, M. C. Sullards, and A. H. Merrill, Jr. 2009. Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers. J. Lipid Res. 50: 1692-1707.
33. de Mello, V. D., M. Lankinen, U. Schwab, M. Kolehmainen, S. Lehto, T. Seppanen-Laakso, M. Oresic, L. Pulkkinen, M. Uusitupa, and A. T. Erkkila. 2009. Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia. 52: 2612-2615.
34. Ichi, I., K. Nakahara, Y. Miyashita, A. Hidaka, S. Kutsukake, K. Inoue, T. Maruyama, Y. Miwa, M. Harada-Shiba, M. Tsushima, et al. 2006. Association of ceramides in human plasma with risk factors of atherosclerosis. Lipids. 41: 859-863.
35. Holland, W. L., and S. A. Summers. 2008. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr. Rev. 29: 381-402.
36. Levy, M., and A. H. Futerman. 2010. Mammalian ceramide synthases. IUBMB Life. 62: 347-356.
37. Riebeling, C., J. C. Allegood, E. Wang, A. H. Merrill, Jr ., and A. H. Futerman. 2003. Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors. J. Biol. Chem. 278: 43452-43459.
38. Nelson, J. C., X. C. Jiang, I. Tabas, A. Tall, and S. Shea. 2006. Plasma sphingomyelin and subclinical atherosclerosis: findings from the multi-ethnic study of atherosclerosis. Am. J. Epidemiol. 163: 903-912.
39. Schlitt, A., S. Blankenberg, D. Yan, H. von Gizycki, M. Buerke, K. Werdan, C. Bickel, K. J. Lackner, J. Meyer, H. J. Rupprecht, et al. 2006. Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease. Nutr. Metab. (Lond). 3: 5.
40. Kolodgie, F. D., A. P. Burke, K. S. Skorija, E. Ladich, R. Kutys, A. T. Makuria, and R. Virmani. 2006. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26: 2523-2529.
41. Schmitz, G., and K. Ruebsaamen. 2010. Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis. 208: 10-18.
42. Gregson, J., H. A. Stirnadel-Farrant, I. U. Doobaree, and C. Koro. 2012. Variation of lipoprotein associated phospholipase A2 across demographic characteristics and cardiovascular risk factors: a systematic review of the literature. Atherosclerosis. 225: 11-21.
43. Bajnok, L., I. Seres, Z. Varga, S. Jeges, A. Peti, Z. Karanyi, A. Juhasz, E. Csongradi, E. Mezosi, E. V. Nagy, et al. 2007. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals. Metabolism. 56: 1542-1549.
44. Angell, R., Y. Mitsuhashi, K. Bigley, and J. E. Bauer. 2009. Plasma LCAT activity and lipid subfraction composition in obese beagles undergoing weight loss. Lipids. 44: 415-424.
45. Felde, R., and G. Spiteller. 1995. Plasmalogen oxidation in human serum lipoproteins. Chem. Phys. Lipids. 76: 259-267.
46. Engelmann, B. 2004. Plasmalogens: targets for oxidants and major lipophilic antioxidants. Biochem. Soc. Trans. 32: 147-150.
47. Ford, D. A. 2010. Lipid oxidation by hypochlorous acid: chlorinated lipids in atherosclerosis and myocardial ischemia. Clin. Lipidol. 5: 835-852.
48. Zhou, J. F., X. F. Yan, F. Z. Guo, N. Y. Sun, Z. J. Qian, and D. Y. Ding. 2000. Effects of cigarette smoking and smoking cessation on plasma constituents and enzyme activities related to oxidative stress. Biomed. Environ. Sci. 13: 44-55.
49. Rahman, I., D. Morrison, K. Donaldson, and W. MacNee. 1996. Systemic oxidative stress in asthma, COPD, and smokers. Am. J. Respir. Crit. Care Med. 154: 1055-1060.